ATELLICA ™ IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 - COFEPRIS Registration 588R2019 SSA
Access comprehensive regulatory information for ATELLICA ™ IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (ATELLICA ™ IM ANTI-HEPATITIS B SURFACE ANTIGEN 2) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 588R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on March 20, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ATELLICA™ IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2) ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUALITATIVA Y CUANTITATIVA DEL TOTAL DE ANTICUERPOS CONTRA EL ANTÍGENO DE SUPERFICIE DE LA HEPATITIS B EN SUERO Y PLASMA (EDT
THE ATELLICA™ IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2) ASSAY IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF TOTAL ANTIBODIES AGAINST HEPATITIS B SURFACE ANTIGEN IN SERUM AND PLASMA (EDT)